Novartis Drug VotubiaR Approved in the EU as First Medication to Treat …

Published November 13, 2012

Novartis drug VotubiaR approved in the EU as first medication to treat …

Filed under: drug treatment news 2012

Novartis International AG / Novartis drug VotubiaR approved in the EU as first medication to treat patients with non-cancerous kidney tumors associated with TSC . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for …
Read more on Reuters

ChemoCentryx Announces Financial Results for the Quarter Ended September …

Filed under: drug treatment news 2012

The decisions are based on the growing body of preclinical data supporting the role for CCR2 inhibition in the treatment of chronic kidney disease, and assessments by the independent data monitoring committee (IDMC). The IDMC evaluated safety …
Read more on Equities.com

Biogen Hemophilia A Therapy Helps in Fewer Injections

Filed under: drug treatment news 2012

Biogen Idec Inc. (BIIB) and partner Swedish Orphan Biovitrum AB (SOBI) said their hemophilia A therapy controlled bleeding with fewer injections in a late-stage study. The companies plan to apply for U.S. approval early next year. The therapy, long …
Read more on Businessweek